[go: up one dir, main page]

EP0724628A4 - TRANSGENIC ANIMAL MODEL FOR THE TREATMENT OF COGNITIVE DISORDERS - Google Patents

TRANSGENIC ANIMAL MODEL FOR THE TREATMENT OF COGNITIVE DISORDERS

Info

Publication number
EP0724628A4
EP0724628A4 EP94922619A EP94922619A EP0724628A4 EP 0724628 A4 EP0724628 A4 EP 0724628A4 EP 94922619 A EP94922619 A EP 94922619A EP 94922619 A EP94922619 A EP 94922619A EP 0724628 A4 EP0724628 A4 EP 0724628A4
Authority
EP
European Patent Office
Prior art keywords
cognitive disorders
treatment
animal model
transgenic animal
transgenic mice
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP94922619A
Other languages
German (de)
French (fr)
Other versions
EP0724628A1 (en
Inventor
Howard Y Chen
Kathryn J Hofmann
Der Ploeg Leonardus H T Van
Alan R Shaw
Myrna E Trumbauer
Hui Zheng
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of EP0724628A1 publication Critical patent/EP0724628A1/en
Publication of EP0724628A4 publication Critical patent/EP0724628A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/545—IL-1
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/20—Animal model comprising regulated expression system
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0306—Animal model for genetic diseases
    • A01K2267/0318—Animal model for neurodegenerative disease, e.g. non- Alzheimer's
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/035—Animal model for multifactorial diseases
    • A01K2267/0368—Animal model for inflammation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Environmental Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Transgenic mice with a human interleukin 1β gene is provided. The transgenic mice may be used to evaluate compounds affecting Alzheimer's Disease and other cognitive disorders.
EP94922619A 1993-07-22 1994-07-19 TRANSGENIC ANIMAL MODEL FOR THE TREATMENT OF COGNITIVE DISORDERS Withdrawn EP0724628A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9694493A 1993-07-22 1993-07-22
US96944 1993-07-22
PCT/US1994/008110 WO1995003397A1 (en) 1993-07-22 1994-07-19 Transgenic animal model for cognitive disorders

Publications (2)

Publication Number Publication Date
EP0724628A1 EP0724628A1 (en) 1996-08-07
EP0724628A4 true EP0724628A4 (en) 1997-07-02

Family

ID=22259870

Family Applications (1)

Application Number Title Priority Date Filing Date
EP94922619A Withdrawn EP0724628A4 (en) 1993-07-22 1994-07-19 TRANSGENIC ANIMAL MODEL FOR THE TREATMENT OF COGNITIVE DISORDERS

Country Status (4)

Country Link
EP (1) EP0724628A4 (en)
JP (1) JPH09500533A (en)
CA (1) CA2167581A1 (en)
WO (1) WO1995003397A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10507637A (en) * 1994-10-20 1998-07-28 メルク エンド カンパニー インコーポレーテッド Interleukin-1β deficient transgenic animal
US5767337A (en) * 1995-07-31 1998-06-16 Duke University Creation of human apolipoprotein E isoform specific transgenic mice in apolipoprotein deficient "knockout" mice
JP3507884B2 (en) * 2000-03-07 2004-03-15 新潟大学長 Objective diagnosis of schizophrenia using gene expression as an index
EP1364578A4 (en) * 2001-02-27 2004-09-15 Japan Government Schizophrenia-like mental disease model animal, method of constructing the same and use thereof
WO2014085911A1 (en) 2012-12-05 2014-06-12 Tornado Medical Systems, Inc. System and method for wide field oct imaging
JP6456015B2 (en) * 2013-07-19 2019-01-23 国立大学法人三重大学 Non-human mammal as a model animal for obstructive arteriosclerosis, a model animal for studying sputum, and a model animal for systemic amyloidosis
EP3196303B1 (en) * 2014-07-31 2020-07-22 Transgenic Inc. Inflammation reporter system
EP3655748B1 (en) 2017-07-18 2023-08-09 Perimeter Medical Imaging, Inc. Sample container for stabilizing and aligning excised biological tissue samples for ex vivo analysis
US20230148575A1 (en) * 2020-04-07 2023-05-18 Biocytogen Pharmaceuticals (Beijing) Co., Ltd. Genetically modified non-human animal with human or chimeric il1b and/or il1a

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988010118A1 (en) * 1987-06-23 1988-12-29 Biogen N.V. Expression of proteins in milk
JPH02207727A (en) * 1989-02-08 1990-08-17 Yuu Honshiyou Trans-genic mouse
WO1991013979A1 (en) * 1990-03-05 1991-09-19 President And Fellows Of Harvard College Transgenic mouse overexpressing il-4 and method of use

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988010118A1 (en) * 1987-06-23 1988-12-29 Biogen N.V. Expression of proteins in milk
JPH02207727A (en) * 1989-02-08 1990-08-17 Yuu Honshiyou Trans-genic mouse
WO1991013979A1 (en) * 1990-03-05 1991-09-19 President And Fellows Of Harvard College Transgenic mouse overexpressing il-4 and method of use

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Section Ch Week 9039, Derwent World Patents Index; Class B04, AN 90-294644, XP002030369 *
See also references of WO9503397A1 *

Also Published As

Publication number Publication date
CA2167581A1 (en) 1995-02-02
JPH09500533A (en) 1997-01-21
WO1995003397A1 (en) 1995-02-02
EP0724628A1 (en) 1996-08-07

Similar Documents

Publication Publication Date Title
EP0778886A4 (en) Transgenic animal expressing a familial form of human amyloid precursor protein
FI933946A7 (en) Compounds useful as hypoglycemic agents and in the treatment of Alzheimer's disease
EP0710283A4 (en) EXPRESSION OF INTERLEUKIN - g (b) HUMAN IN A TRANSGENIC ANIMAL
MY131458A (en) Pyrolopyrimidine compounds
NO943256L (en) The use of 2-amino 6-trifluoromethoxy benzothiazole (Riluzole) to obtain a drug for use in the treatment of motoneuron disorders
EP0769903A4 (en) GENE FOR INDUCTIBLE NITRIC OXIDE SYNTHASE FOR THE TREATMENT OF DISEASES
DE69627153D1 (en) COMPOSITIONS FOR ACHIEVING ANALGESIA AND INHIBITING THE PROGRESSION OF NEUROPATHIC PAIN DISEASES
FR2697162B1 (en) Use of modafinil for the manufacture of a medicament for the treatment of urinary incontinence and urethro vesical sphincter disorders.
FR2611729B1 (en) PROCESS FOR THE PREPARATION OF AN ACRYLATE AND / OR METHACRYLATE ORGANOPOLYSILOXANE
IL105216A0 (en) Method and kit for the diagnosis of alzheimer's disease
TNSN99135A1 (en) NEUROPROTECTIVE COMPOSITION FOR THE PREVENTION AND / OR TREATMENT OF NERVOUS OR BEHAVIORAL DISORDERS DUE TO ANXIETY OR DEPRESSION
EP0724628A4 (en) TRANSGENIC ANIMAL MODEL FOR THE TREATMENT OF COGNITIVE DISORDERS
FI953915L (en) To relieve Dupuytren's disease
ZA93218B (en) Heterocyclic compounds and their preparation and use.
EP0270690A4 (en) MEDICINE FOR THE TREATMENT AND PROPHYLAXIS OF KIDNEY AND LIVER DISEASES.
ES2063060T3 (en) BENZAMIDE AGAINST COGNOSCITIVE DISEASES.
NO20002649L (en) Use of a mixture of diol and an alpha-hydroxy acid for the treatment of hyperkeratotic skin disorders
AU6110490A (en) 5-methyl-isoxazole-4-carboxylic acid anilides and 2-hydroxyethylidene-cyano acetic acid anilides for the treatment of ocular diseases
ATE111354T1 (en) 2,3-DIHYDROERGOLINES TO INCREASE SEROTONERGIC FUNCTIONS.
FR2741355B1 (en) COMPOSITION FOR THE TREATMENT OF OBJECTS TO BE CLEANED AND / OR DISINFECTED
FR2619713B1 (en) APPLICATION OF AMINO-2 TRIFLUOROMETHOXY-6 BENZOTHIAZOLE TO OBTAIN MEDICINE FOR THE TREATMENT OF SLEEP AND DEPRESSION DISORDERS
PL338242A1 (en) Novel compounds exhibiting an activity promoting differentation of neurones
FI824276A7 (en) Composition for the diagnosis and treatment of amyotrophic lateral sclerosis, Parkinson's disease and Alzheimer's disease
BE860992A (en) COMPOSITION AND BUFFER FOR THE TREATMENT OR PREVENTION OF ACNE AND SIMILAR SKIN DISORDERS
BE878703A (en) COMPOSITION FOR INJECTION FOR THE TREATMENT OF HELMINTHIASIS AND CLOSTRIDIUM DISEASES IN ANIMALS

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19960222

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 19970521

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE

RHK1 Main classification (correction)

Ipc: C12N 15/00

17Q First examination report despatched

Effective date: 20020219

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20020702